DNAVSENLV• 28 Days (Normalized)
DNA vs ENLV (Ginkgo Bioworks Holdings Inc. vs Enlivex Ltd.)
Showing Closing Date Range from Sep 1 to Sep 29, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
DNA Performance $10.46
+%
Ginkgo Bioworks Holdings Inc.
Normalized Baseline0.00%
ENLV Performance $0.48
-62.49%
Enlivex Ltd.
Normalized Baseline0.00%
Alpha Spread Margin DNA LEADS
+62.49 pts
DNA outperforming by 62.49 percentage points
DNAENLV
Spread Trajectory28 Days (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
DNA ENLV
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(20 dates)
| Date | DNA Price | DNA Gain (%) | ENLV Price | ENLV Gain (%) | Spread |
|---|---|---|---|---|---|
| Sep 29, 2026 | $- | $0.48 | -62.49% | - | |
| Sep 28, 2026 | $10.46 | +50.94% | $0.51 | -59.84% | +110.78% |
| Sep 25, 2026 | $10.66 | +53.82% | $0.60 | -53.28% | +107.10% |
| Sep 24, 2026 | $10.25 | +47.91% | $0.61 | -52.66% | +100.57% |
| Sep 23, 2026 | $8.58 | +23.81% | $0.64 | -50.00% | +73.81% |
| Sep 22, 2026 | $9.37 | +35.21% | $- | - | |
| Sep 21, 2026 | $7.98 | +15.15% | $0.69 | -45.86% | +61.01% |
| Sep 18, 2026 | $7.88 | +13.71% | $0.81 | -36.95% | +50.66% |
| Sep 17, 2026 | $7.84 | +13.13% | $0.73 | -43.20% | +56.33% |
| Sep 16, 2026 | $7.06 | +1.88% | $0.81 | -36.64% | +38.52% |
| Sep 15, 2026 | $6.99 | +0.87% | $0.88 | -31.02% | +31.89% |
| Sep 14, 2026 | $7.01 | +1.15% | $0.86 | -32.46% | +33.61% |
| Sep 11, 2026 | $6.75 | -2.60% | $0.96 | -25.00% | +22.40% |
| Sep 10, 2026 | $6.78 | -2.16% | $0.98 | -23.36% | +21.20% |
| Sep 09, 2026 | $6.79 | -2.02% | $1.04 | -18.75% | +16.73% |
Page 1 of 2